Metoclopramide does not inhibit atrial natriuretic factor-stimulated diuresis in man

Aviation Space and Environmental Medicine

Volumn 67, Issue 3, 1996, Pages 248-252

  Farrow, Stephen ^a   Mahayni, Amer ^b   Banta, Guy ^b   Sowers, James ^b   Lockette, Warren ^b  

^a DETROIT RECEIVING HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANARITIDE; ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; METOCLOPRAMIDE; MINERALOCORTICOID; POTASSIUM ION; SODIUM ION;

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; DRUG MECHANISM; DRUG MIXTURE; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPERVOLEMIA; KALIURESIS; MICROGRAVITY; MOTION SICKNESS; NATRIURESIS; NAUSEA; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; WATER IMMERSION;

ADRENOCORTICOTROPIC HORMONE; ALDOSTERONE; ANTIEMETICS; ATRIAL NATRIURETIC FACTOR; DIURESIS; DOPAMINE ANTAGONISTS; HUMANS; MALE; METOCLOPRAMIDE; NATRIURESIS;

EID: 0029869496     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Blumberg A, Dubb J, Allison N, Aldins Z, Ramey K, Stote R. Selectivity of metoclopramide for endocrine versus renal effects of dopamine in normal humans. J Cardiovasc Pharmacol 1988; 11:181-6.
2. Chartier L, Schiffrin E, Thibault G, Garcia R. ANF inhibits the stimulation of aldosterone secretion by angiotensin II, ACTH and potassium in vitro, and angiotensin II-induced steroidogenesis in vivo. Endocrinology 1984; 115:2026-9.
3. Farrow S, Mers A, Banta G, Lockette W, Schallhorn S, May R, Rydstedt L, Cadaret L. Vasopressin inhibits diuresis induced by water immersion in humans. J Appl Physiol 1992; 73:932-6.
4. Gollapudi K, Danovich G, Sowers J. Catecholamine responses to central volume expansion produced by head-out water immersion and saline infusion. J Clin Endocrinol Metab 1983; 56:998-1002.
5. Hughes J, Beck T, Rose C, Carey R. The effect of selective dopamine-1 receptor stimulation on renal and adrenal function. J Clin Endocrinol Metab 1988; 66:518-25.
6. Laragh J. The endocrine control of blood volume, blood pressure, and sodium balance: ANF and renin systems interaction. J Hypertension 1986; 4(Suppl 2)5143-57.
7. McMurray J, Coutie W, McFarland L, Struthers A ANF inhibits ACTH-stimulated aldosterone but not Cortisol secretion in man. Eur J Clin Pharmacol 1988; 35:409-12.
8. Murphy M, Bass A, Goldberg L. Renal effects of ANF are independent of dopamine-1 receptors. Am J Physiol 1988; 255:F494-9.
9. Sommers D, Meyer E, van Wyk M, de Villiers L. Aldosterone response to metoclopramide is mediated through the autonomic nervous system in man. Eur J Clin Pharmacol 1988; 33:609-12.
10. Sowers J, Berg G, Martin V, Mayes D. Dopaminergic modulation of aldosterone secretion in the Rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone. Endocrinology 1982; 110:1173-7.
11. Sowers J, Berg G, Tuck M, Martin V, Chandler W, Mayes D. Dopaminergic modulation of 18-hydroxycorticosterone secretion in man. J Clin Endocrinol Metab 1982; 54:523-7.
12. Takagi M, Takagi M, Franco-Saenz R, Mulrow P, Reimann E. Effects of dibutyryl adenosine 3′-5′-monophosphate, angiotensin II and ANF on phosphorylation of a 17,600-Dalton protein in adrenal glomerulosa cells. Endocrinology 1988; 123:2419-23.
13. Volpe M, Cuocolo A, Vecchione F, Mele A, Condorelli M, Trimarco B. Vagal mediation of the effects of ANF on blood pressure and arterial baroflexes in the rabbit. Circ Res 1987; 60:747-55.
14. Wilkins M, Kendall M, Lote C, West M, Wood J. Partial attenuation of the renal response to high dose infusion of atrial natriuretic peptide by carbidopa. J Hypertension 1986; 4(Suppl 5):S83-5.